Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 90

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 90
---
Restricted stock units

        135,612

        97,808

        52,601

         Employee stock purchase plan

        7,266

        5,234

        5,549

        Subtotal
         
        $
        205,133

        $
        182,514

        $
        233,018

        Capitalized stock-based compensation costs*

        (20,833
        )

        —

        —

        Total stock-based compensation expense included in expenses
         
        $
        184,300

        $
        182,514

        $
        233,018

        Research and development

        74,010

        82,489

        61,293

        Selling, general and administrative

        110,290

        100,025

        171,725

        Total stock-based compensation expense included in expenses
         
        $
        184,300

        $
        182,514

        $
        233,018

      *Prior to the year ended December 31, 2024, capitalized stock-based compensation costs were not material.As of December 31, 2024, there was $238.5 million of total unrecognized stock-based compensation expense related to the Company’s stock-based compensation plans, including estimated forfeitures. The expense is expected to be recognized over a weighted-average period of approximately two years. Of this amount, $72.9 million related to options with service conditions only, $7.9 million related to PSUs with certain performance conditions not met and the remaining $157.7 million related to restricted stock units with service conditions only.

16. 401(K) PLANThe Company sponsors a 401(k) Plan in the U.S. and other retirement plans (“the Plan”) in the rest of the world, all of which are defined contribution plans. The Plan is available to all employees who are age 21 or older. Participants may make voluntary contributions and the Company makes matching contributions according to the Plan’s matching formula. Matching contributions fully vest after one year of service for all employees. The expense related to the Plan primarily consists of the Company’s matching contributions.Expense related to the Plan totaled $9.8 million, $8.8 million and $6.5 million for the years ended December 31, 2024, 2023 and 2022, respectively.

17. OTHER INCOME (LOSS), NETThe following table summarizes other income